Status:
COMPLETED
Effects of Telemedical Support on Therapeutic Results of CPAP Patients
Lead Sponsor:
Facharztzentrum Sonneberg-Coburg uBAG
Collaborating Sponsors:
Heinen und Löwenstein GmbH & Co. KG
Conditions:
Obstructive Sleep Apnea
Adherence, Treatment
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Obstructive sleep apnea (OSA) is a type of sleep-related breathing disorders that is characterized by a sleep-related constriction (obstruction) of the upper airways. The treatment with continuous app...
Detailed Description
Clinical Picture From the epidemiological view obstructive sleep apnea (OSA) is the most common type of sleep-related breathing disorders (SRBD). OSA is characterized by a sleep-related constriction (...
Eligibility Criteria
Inclusion
- age 18-80 years
- CPAP-naïve
- confirmed severe OSA (AHI \>30/h), diagnosis based on polysomnography (PSG) (MiniScreen PRO with Software MiniscreenViewer, Dr. Fenyves \& Gut, Rangendingen, Germany)
- written informed consent to participate in the study, including a data protection statement.
Exclusion
- presence of a contraindication to PAP therapy
- participation in another study influencing automated electronic support
- lack of possibility to receive emails or use electronic means of communication
- lack of patient consent.
Key Trial Info
Start Date :
February 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05440279
Start Date
February 19 2019
End Date
March 31 2022
Last Update
June 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Facharztzentrum Coburg Sonneberg
Sonneberg, Thuringia, Germany, 96515